MarketsnMarkets

Growth of cytotoxics will remain static over the forecast period with a CAGR of -0.1%.

Antihormonal cancer therapies are a class of drugs used predominantly in the treatment of breast cancer and prostate cancer.

Antihormonal cancer therapies are a class of drugs used predominantly in the treatment of breast cancer and prostate cancer.

In 2008, antiretroviral sales across the seven major markets totaled $10.7 billion, growing at a CAGR of 12.8% between 2005 and 2008.

In 2009, hepatitis B sales across the seven major markets totalled $954m, demonstrating a CAGR of 37.5% between 2005 and 2009.

This model contains a ten year commercial forecast of hepatitis B drug sales by country, class, molecule and brand across the US, Japan, France, Germany, Italy, Spain, UK and Turkey.

The majority of new LPO business from both law firms and enterprise legal functions - is now tending to go to these emerging brand leaders and their relative position is therefore likely to strengthen.

China has been producing diethyl maleate for several years, but the market is not very flourishing at present.

Despite advances in the management of the disease, outcomes remain poor for patients with advanced epithelial ovarian cancer.

As a result of the global financial crisis governments and regulators demand greater transparency in OTC markets through central clearing and even trading on exchanges.